Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.37 |
| ▸ | CD81 | P60033 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid SCHEMBL10831770 | 0.90 | LMNA (0.36) | ALDH1A1CD81 | |
| Acrylic Acid SCHEMBL10831760 | 0.90 | LMNA (0.36) | ALDH1A1CD81 | |
| SCHEMBL26472 | 0.88 | CD81 (0.37) | CD81 | |
| SCHEMBL26471 | 0.88 | CD81 (0.37) | CD81 | |
| Vinylsulfonic Acid SCHEMBL8934180 | 0.86 | CD81 (0.33) | CD81 | |
| Vinylsulfonic Acid SCHEMBL8934187 | 0.86 | CD81 (0.33) | CD81 | |
| SCHEMBL16318562 | 0.86 | CD81 (0.36) | CD81 | |
| SCHEMBL3174345 | 0.86 | CD81 (0.36) | CD81 | |
| SCHEMBL9998853 | 0.86 | CD81 (0.36) | CD81 | |
| SCHEMBL11264760 | 0.86 | CD81 (0.36) | CD81 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210393481-A1 | SYSTEMS AND METHODS FOR PRESERVATIVE REMOVAL FROM OPHTHALMIC FORMULATIONS COMPRISING COMPLEXING AGENTS | TearClear Corp. | 2021-12-23 | — | — | US | disclosed |
| US-20200246222-A1 | Systems and Methods for Preservative Removal from Ophthalmic Formulations Comprising Complexing Agents | TearClear Corp. | 2020-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200246222-A1 | Systems and Methods for Preservative Removal from Ophthalmic Formulations Comprising Complexing Agents | SMURF1, CRYAA, PON1 | ALDH1A1 1008/4885TSHR 2245/4885FGFR4 4771/4885 |
| US-20210393481-A1 | SYSTEMS AND METHODS FOR PRESERVATIVE REMOVAL FROM OPHTHALMIC FORMULATIONS COMPRISING COMPLEXING AGENTS | SMURF1, CRYAA, PON1 | ALDH1A1 1008/4885TSHR 2245/4885FGFR4 4771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.